by Robert F. Todd, Scott D. Gitlin, Linda J. Burns, and

Slides:

Advertisements

Similar presentations

Validation of a flow cytometric scoring system as a prognostic indicator for posttransplantation outcome in patients with myelodysplastic syndrome by Bart.

Advertisements

Prevalence and prognostic implications of CEBPA mutations in pediatric acute myeloid leukemia (AML): a report from the Children's Oncology Group by Phoenix.

Generating AML-Specific Peripheral Blood Autologous Cytotoxic T-Lymphocytes (CTLs)‏ by Rohtesh S. Mehta, Xiaohua Chen, Antony Jeyaraj, and Paul Szabolcs.

Formation of human hepatocytes by human hematopoietic stem cells in sheep by Graça Almeida-Porada, Christopher D. Porada, Jason Chamberlain, Ali Torabi,

Omega-3 Fatty Acid Blood Levels by H. Robert Superko, Scott M. Superko, Khurram Nasir, Arthur Agatston, and Brenda C. Garrett Circulation Volume 128(19):

Constitutive NF-κB and NFAT activation leads to stimulation of the BLyS survival pathway in aggressive B- cell lymphomas by Lingchen Fu, Yen-Chiu Lin-Lee,

Type of Scholarships and Grants Seniors Reported Having Received in Selected Years 1990 to 2015, by Percentage of Total Respondents for Each Year State.

The influence of high-altitude living on body iron

Uncontrolled Wnt signaling causes leukemia

Comparable results of umbilical cord blood and HLA-matched sibling donor hematopoietic stem cell transplantation after reduced-intensity preparative regimen.

by Robert A. Kyle, Morie A. Gertz, Philip R. Greipp, Thomas E

Central venous line–related thrombosis in children: association with central venous line location and insertion technique by Christoph Male, Peter Chait,

MBL: mostly benign lymphocytes, but…

by Henrik Frederiksen, and Kai Schmidt

Finding a diamond in the (mouse is) rough

A Clinical Evaluation of the International Lymphoma Study Group Classification of Non-Hodgkin's Lymphoma Blood Volume 89(11): June 1, 1997 ©1997.

Detection of vascular endothelial growth factor in AIDS-related primary effusion lymphomas by Yoshiyasu Aoki, Giovanna Tosato, Yoshihiro Nambu, Aikichi.

Hypertension and Diabetes Mellitus in Adult and Pediatric Survivors of Allogeneic Hematopoietic Cell Transplantation Navneet S. Majhail, MD, MS, Tejo.

Tax fingerprint in adult T-cell leukemia

One giant leap for pediatric AMKL

How I treat elderly patients with myeloma

Nonmyeloablative conditioning for relapsed follicular lymphoma

An Unusual Cause of Abdominal Pain in Sickle Cell Disease

by Corey S. Cutler, John Koreth, and Jerome Ritz

Genetic sequence analysis of inherited bleeding diseases

A Phase 2 Study of Bortezomib Combined with Reinduction Chemotherapy in Children and Young Adults with Recurrent, Refractory or Secondary Acute Myeloid.

In situ identification of allospecific B cells using pentamers

Mutation Analysis of the Rearranged Immunoglobulin Heavy Chain Genes of Marginal Zone Cell Lymphomas Indicates an Origin From Different Marginal Zone B.

Clinical importance of ADAMTS13 activity during remission in patients with acquired thrombotic thrombocytopenic purpura by Evaren E. Page, Johanna A. Kremer.

Rank-order bar chart of percentage of patient-days with blood glucose results > 299 mg/dl for non-ICU units. Rank-order bar chart of percentage of patient-days.

Relationship of p53, bcl-2, and Tumor Proliferation to Clinical Drug Resistance in Non-Hodgkin's Lymphomas by Wyndham H. Wilson, Julie Teruya-Feldstein,

Weekly polyethylene glycol conjugated L-asparaginase compared with biweekly dosing produces superior induction remission rates in childhood relapsed acute.

How we choose factor VIII to treat hemophilia

Alloimmunization and erythrocyte autoimmunization in transfusion-dependent thalassemia patients of predominantly Asian descent by Sylvia T. Singer, Vivian.

Taking a leaf from the book of oral tolerance

Incidence, clinical course, and prognosis of secondary monoclonal gammopathy of undetermined significance in patients with multiple myeloma by Rishi K.

by Douglas D. Ross, Judith E. Karp, Tar T. Chen, and L. Austin Doyle

Patients’ priorities in selecting chronic lymphocytic leukemia treatments by Carol Mansfield, Anthony Masaquel, Jessie Sutphin, Elisa Weiss, Meghan Gutierrez,

Has MRD monitoring superseded other prognostic factors in adult ALL?

CVP chemotherapy plus rituximab compared with CVP as first-line treatment for advanced follicular lymphoma by Robert Marcus, Kevin Imrie, Andrew Belch,

Treatment-related risk factors of inhibitor development in previously untreated patients with hemophilia A: the CANAL cohort study by Samantha C. Gouw,

by Martin S. Tallman, Donna Neuberg, John M. Bennett, Christopher J

PWD confidence with key diabetes management activities.

Long-term acquisition of allergen-specific IgE and asthma following allogeneic bone marrow transplantation from allergic donors by Teal S. Hallstrand,

by Hideki Yoshioka, Hiromi Sato, Hiroto Hatakeyama, and Akihiro Hisaka

Chronic graft-versus-host disease

by Seth J. Rotz, Nathan Luebbering, Bradley P

by Santosh L. Saraf, Xu Zhang, Tamir Kanias, James P. Lash, Robert E

Average Debt Among All Graduating Students by Type of School

Interhospital variation in pharmacologic treatment of neonates with NAS and NICU admission among pharmacologically-treated neonates with NAS from 2013.

Catherine M. Pound et al. Hospital Pediatrics 2017;7:

Distribution of average number of joint bleeds across factor activity level by age groups for patients with hemophilia B. In the boxplots, the central.

by H. Ddungu, M. Waiswa, R. Kruisselbrink, P. Kagoma, and M. Crowther

Association between hospital-level diagnostic testing and admission percentage for patients with AGE at 34 US children’s hospitals. Association between.

Increase in adults treated at children's hospitals, 1999–2012, according to age group. Increase in adults treated at children's hospitals, 1999–2012, according.

Bar graph of the number of averaged activated voxels (normalized to control values), as defined by increases in lactate concentration in the left frontal.

Erratum in Ledru et al. Alteration of tumor necrosis factor–α T-cell homeostasis following potent antiretroviral therapy: contribution to the development.

CD16 uses additional pathways for killing.

Rituximab immunotherapy: it’s getting personal

Mesenchymal Stem Cell-Derived Vesicles Reverse Hematopoietic Radiation Damage by Sicheng Wen, Laura R Goldberg, Mark S Dooner, John L Reagan, and Peter.

General Medical Council’s (GMC) National Training Survey results for average clinic attendance per week at 33 sites across the UK in General Medical.

A binding relationship with thrombin

Promising Progression Free and Overall Survival Using a Novel (CY/FLU/TBI) Reduced-Intensity Conditioning (RIC) Regimen for Allogeneic Sibling Stem Cell.

Survival of children with sickle cell disease

A Novel Risk Assessment Model to Predict Venous Thromboembolism (VTE) in Cancer Inpatients: The Canclot Score by Dana E. Angelini, M. Todd Greene, Julie.

Safety and pharmacokinetics of a novel recombinant fusion protein linking coagulation factor IX with albumin (rIX-FP) in hemophilia B patients by Elena.

by Victor A. Chow, Mazyar Shadman, and Ajay K. Gopal

Cold agglutinin disease

Mean BMI z scores in 6- to 9-year-old white girls with and without breast development, based on the PROS study data reported by Kaplowitz et al.13 The.

Volume of milk consumed at a breastfeeding from the more productive breast (□) and the less productive breast (□) during the morning (4:01 am to 10:00.

Presentation transcript:

by Robert F. Todd, Scott D. Gitlin, Linda J. Burns, and Subspeciality training in hematology and oncology, 2003: results of a survey of training program directors conducted by the American Society of Hematology by Robert F. Todd, Scott D. Gitlin, Linda J. Burns, and Blood Volume 103(12):4383-4388 June 15, 2004 ©2004 by American Society of Hematology

Training program director preferences about the optimal duration of the required continuity clinic experiences. Training program director preferences about the optimal duration of the required continuity clinic experiences. The vertical bars indicate the percentage of training program directors with the indicated preferences regarding the duration of the continuity clinic. Robert F. Todd III et al. Blood 2004;103:4383-4388 ©2004 by American Society of Hematology

Career pathways selected by graduates of adult and pediatric training programs over the past 3 years. Career pathways selected by graduates of adult and pediatric training programs over the past 3 years. The horizontal bars indicate the mean percentage of training graduates (as reported by training program directors) who have left the program to start careers in the indicated pathways. Robert F. Todd III et al. Blood 2004;103:4383-4388 ©2004 by American Society of Hematology